Foot-and-mouth disease virus (FMDV) is the causative agent of foot-and-mouth disease (FMD), a highly contagious disease of cloven-hoofed animals, including cattle, swine, goats, sheep, and other species of wild ruminants. The virus exhibits a remarkable adaptation and serological diversity exemplified by the existence of a large number of subtypes within each serotype and the fact that infected animals can also become persistent carriers (2, 3, 27, 49) . In infected animals the virus replicates very rapidly and spreads among in-contact susceptible animals by aerosol or direct contact. Clinical signs of FMD, including vesicles on the feet and the mouth, can appear as early as 2 days after virus exposure (reference 20 and references therein).
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FMDV is the type species of the Aphthovirus genus of the family Picornaviridae. The viral genome, consisting of a single open reading frame, is flanked by a long 5Ј-nontranslated region (NTR) linked to a small viral peptide, VPg, and a short 3ЈNTR followed by a poly(A) tail (Fig. 1a) . Four structural proteins (VP1 to VP4) constitute the viral capsid, and a number of essential nonstructural proteins, including the RNAdependent RNA polymerase (3D pol ), are involved in the replication of viral RNA (reviewed in references 7 and 45).
The first step in FMDV infection involves the recognition of a cell surface receptor. An Arg-Gly-Asp (RGD) amino acid sequence located within the ␤G-␤H (G-H) loop of the capsid protein VP1 (1, 28, 30 ) is known to bind to several integrins of the ␣ V subgroup, including ␣ V ␤ 1 , ␣ V ␤ 3 , ␣ V ␤ 6 , and ␣ V ␤ 8 , and is involved in virus attachment to cells and interaction with neutralizing antibodies (8, 18, 21, 24-26, 34, 36, 39, 40, 52) . The generation of genetically engineered virions carrying deletions or mutations of the RGD motif leads to virus which is unable to bind to cultured cells or cause disease in susceptible animals (29, 34, 37, 43) .
In cell culture, FMDV binds preferentially to one or more of the above-mentioned integrins with different specificities, and integrin utilization varies between serotypes (7, 17, 18) . The reason for this specificity is not clearly understood; however, it is known that sequences surrounding the RGD motif, or located in other regions of the viral capsid, could induce structural changes in the G-H loop of VP1 and modulate binding specificity (14, 42) . These changes may occur with the replacement of only one or a few amino acids at the surface of the virus (reviewed in reference 7). Viruses propagated in vitro can exploit alternative mechanisms to bind and enter the host cell independent of integrin binding. Among them, the use of heparan sulfate has been correlated with the acquisition of positively charged amino acids on the virus capsid surface (19, 22, 48) . It has also been suggested that there might be other, still-undefined FMDV receptors (5, 31, 53) . Despite these observations, there is no evidence of utilization of these alternative receptors in vivo, and the information currently available indicates that FMDV utilizes integrins for entry in the natural host (6, 40 ; reviewed in references 23 and 33) .
The RGD motif is highly conserved among FMDV field isolates, and changes occurring within the G-H loop appear to be the result of antigenic or environmental selective pressures, including cell culture propagation (9, 15, 42, 46, 51) . As a result of serial experimental infection with a prototype strain of A 24 Cruzeiro (A 24 Cru) in naïve cattle using tongue inoculation, a variant (A 24 -B9) was isolated in Colombia with an SGD sequence in the cell receptor recognition site of VP1 instead of the usual RGD sequence. This virus was characterized in our laboratory by a distinctive turbid plaque phenotype and low affinity for BHK-21 cells. Interestingly, a type A FMDV (A 10 61) field isolate from Argentina with an SGD in this position has been documented (FMDV-A10, Argentina/61; GenBank accession number V01130). Passage of the A 24 -B9 virus in BHK-21 cells in our laboratory resulted in the rapid selection of viruses that grew to higher titers, produced clear plaques, and contained an RGD sequence. Immunization of cattle with an inactivated vaccine prepared from tissue culturegrown derivatives of A 24 -B9 has been associated with reduced vaccine protection following challenge with the SGD-containing virus. In the present study we report the phenotypic and genetic characterization of the A 24 -B9 isolate and analyze the receptor utilization and in vitro replication of molecularly cloned SGD mutant viruses containing additional changes in a conserved amino acid upstream of this motif. Furthermore, we have compared the pathogenesis of SGD-and RGD-contain- ing viruses by direct inoculation and contact transmission in cattle.
MATERIALS AND METHODS

Viruses and virus passages in vitro.
The FMDV type A 24 Cru used to construct the infectious cDNA clone, pA 24 Cru, was recovered from the vesicular fluid of a foot lesion of a bovine inoculated with A 24 Cru virus intradermally into the tongue (38) and provided by Marvin Grubman (Foreign Animal Disease Research Unit, USDA Agricultural Research Service, Plum Island Animal Disease Center, Greenport, NY). The virus was used directly for RNA extraction and first-strand cDNA synthesis without any passage in tissue culture. The variant A 24 -B9 strain, obtained from the Empresa Colombiana de Productos Veterinarios (Vecol) in Bogota, Colombia, was recovered from the lesions of the ninth serial passage of A 24 Cru in bovine tongue. A 24 -B9R7 virus is a tissue culture derivative of the A 24 -B9 virus, also provided by Vecol, following seven passages of the B9 virus in BHK-21 cells. Accession numbers for the complete sequence of A 24 Cru and the P1 region of A 10 61 viruses are AY593768 and V01130, respectively.
Construction of genome-length infectious cDNA of A 24 Cru and derivation of G-H loop VP1 mutants. Plasmid pA 24 Cru is an infectious cDNA clone of FMDV A 24 Cru constructed by using a long reverse transcription-PCR (RT-PCR) method previously described (32) . Briefly, total viral RNA was extracted from vesicular fluid of an infected animal using TRIzol (Life Technologies) and used as a template for first-strand cDNA synthesis with SuperScript II polymerase (Life Technologies) by using specific oligonucleotide primers (P15, 5Ј-GGCGG CCGCTTTTTTTTTTTTTTT-3Ј; P665, 5Ј-TTACGTCTCGGGGGGGGGGGG GGGGGGGGGG-3Ј). Amplicons, corresponding to the S-fragment and a 920-nucleotide fragment of A 24 Cru that follows the poly(C), were obtained by amplification of homopolymer-tailed cDNAs and primer pairs P722 (5Ј-TATC CCGGGTTCTTGAAAGGGGGCGCTAGGG-3Ј) with P665 (5Ј-TTACGTCT CGGGGGGGGGGGGGGGGGGGGGG-3Ј) and P724 (5Ј-TTACGTCTCCC CCCTAAGTTTTACCG-3Ј) with P725 (5Ј-CGATAGCTTCAAGAGTGAGGT TCTCG-3Ј) with Herculase high-fidelity polymerase (Stratagene, La Jolla, CA). Following endonuclease digestion with EspI/SmaI and EspI/(partial) XbaI, respectively, the fragments were inserted into the SmaI and XbaI sites in a vector derived from the type A 12 infectious cDNA plasmid, pRMC 35 , as previously described (32, 44) . This vector contains a T7 promoter sequence upstream of a hammerhead ribozyme at the 5Ј end of the FMDV genome (32) and was modified by EcoRI digestion and religation to eliminate most of the viral open reading frame. Construction of pA 24 Cru was accomplished by replacement of SmaI-to-XbaI fragments derived from the A 24 Cru isolate into this acceptor vector. The final step in the construction of pA 24 Cru consisted of the insertion of a 7.5-kb PCR product utilizing the oligonucleotide P741 (5Ј-ACTCAAGCACT GGTGACAGGCTAAGG-3Ј) and P15 (see above), which was engineered to add a NotI site following the viral poly(A) tail sequence. Following amplification, the DNA fragment was purified from agarose gels with QIAGEN columns (Valencia, CA), digested with NotI and XbaI restriction enzymes, and inserted into pA 24 (SmaI-XbaI) digested with XbaI and EagI enzymes to create pA 24 Cru.
The nucleotide sequence of pA 24 Cru was determined using selected oligonucleotides and the ABI PRISM Big Dye Terminator Cycle Sequencing Ready Reaction kit v3.0 (Applied Biosystems), followed by resolution on an ABI PRISM 310 genetic analyzer (Applied Biosystems). PCR site-directed mutagenesis within the G-H loop of VP1 was carried out by mixing PCR-amplified fragments using mutagenic oligonucleotides, reamplifying the purified products with flanking oligonucleotides, and then digesting and cloning into the NdeI/ BglII sites of pA 24 Cru. In all cases, the resulting cDNA clones were sequenced through the entire amplified regions to confirm the presence of expected modifications and absence of unwanted substitutions.
Cell lines and plaque assays. Baby hamster kidney, strain 21, clone 13 (BHK-21) cells were maintained in Eagle's basal medium containing 10% calf serum (HyClone, South Logan, UT) and 10% tryptose phosphate broth. BHK3 cells are a derivative of BHK-21 cells, obtained from Vecol, which have been adapted to grow in either suspension or monolayer culture and were maintained in the same medium as BHK-21 cells but containing 10% fetal bovine serum. BHK3-␣ V ␤ 6 is a stable cell line expressing the bovine ␣ V ␤ 6 integrin, propagated in Eagle's basal medium containing 10% calf serum, with the addition of G418 and zeocin (Invitrogen) and has been previously described (18) . These cells were periodically monitored for integrin expression by immunohistochemistry (18) . COS-1 cells were maintained in Dulbecco's minimal essential medium containing 10% fetal bovine serum and an additional 2 mM L-glutamine and 1 mM sodium pyruvate. Secondary cultures of fetal bovine kidney cells (FBK) were maintained as previously described (41) . All tissue culture reagents were obtained from Life Technologies, Gaithersburg, MD. Plaque assays were performed using tragacanth overlay and crystal violet staining as previously described (44) . Virus titers were determined on BHK-21 and BHK3-␣ V ␤ 6 cells and are expressed as either PFU/ml or by calculating the 50% tissue culture infectious dose (TCID 50 ) as described elsewhere (41) .
In vitro RNA synthesis and transfection. Plasmids containing genome-length cDNAs were linearized at the SwaI site in the vector sequence following the poly(A) tract and used as templates for RNA synthesis using the MegaScript T7 kit (Ambion, Austin, TX), following the manufacturer's protocols. BHK-21 cells were transfected with these synthetic RNAs using Lipofectin (Life Technologies) as previously described (44) .
Transient expression of bovine integrins in COS-1 cells and infectivity assays. Expression of integrin subunits in COS-1 cells and virus replication assays were performed as previously described (17, 39) . Briefly, cells were transfected with 2 g each of cDNAs encoding the bovine ␣ V subunit and either the ␤ 1 , ␤ 3 , or ␤ 6 subunits using Fugene 6 (Boehringer Mannheim, Indianapolis, IN) according to the manufacturer's protocol. Cells were infected 1 day after transfection and labeled with [ 35 S]methionine from 4 to 18 h postinfection. Equal numbers of trichloroacetic acid-precipitable counts were immunoprecipitated with type-specific polyclonal antibodies, and viral protein synthesis in infected cells was analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis as described elsewhere (39) .
Animal studies. Experiments were performed following protocols approved by the PIADC Animal Care and Use Committee in secure facilities at the Plum Island Animal Disease Center. Two 200-to 250-kg Holstein steers, housed in separate rooms, were inoculated intradermally in the tongue (IDL) at five sites per each of a series of 10-fold dilutions containing 2.1 ϫ 10 4 to 2.1 PFU/site of RGD/A 24 Cru (bovine 21) or 2.4 ϫ 10 4 to 2.4 PFU/site of SGD/A 24 Cru (bovine 22) in 50 l of tissue culture medium. Bovine tongue titers, expressed as 50% bovine infectious IDL doses (BID 50 ), were determined on inoculated animals as described previously (48) . Two days postinoculation (dpi), naïve contact steers (bovines 15 and 18) were moved into each room. All animals were monitored daily for rectal temperature and sedated for clinical examination and sample collection. Lesion scores were based on sites affected that were clearly distinct from inoculation sites and determined by the following criteria: mouth, nostril, or tongue lesion beyond inoculation site ϭ 1; one or more lesions per foot ϭ 1. The maximum score is 5.
Serology and virus isolation. Virus in blood, vesicles, and swab samples (collected on selected days) was titrated by standard plaque assay in BHK-21 and BHK3-␣ V ␤ 6 cells, and viral RNA was extracted from these samples, reverse transcribed, and sequenced through the entire P1 region as described above. Serum samples were collected at 0, 7, 14, and 21 days in inoculated (dpi) and contact animals and tested for the presence of neutralizing antibodies against FMDV in a serum microneutralization assay according to the method of Rweyemamu et al. (47) . Neutralizing titers were reported as the reciprocal of the last serum dilution to neutralize 100 TCID 50 of homologous FMDV in 50% of the wells.
Plasma samples (heparinized blood) were collected at 2 dpi in inoculated animals and aliquots were frozen at Ϫ70°C. In contact animals, plasma and nasal swabs were collected the day the animals were placed in contact (day zero) and daily for seven consecutive days. The presence of virus in blood and vesicle samples was examined by duplicate inoculation of monolayers of BHK-21 and BHK3-␣ V ␤ 6 cells in six-well plates. The cell monolayers were incubated at 37°C and examined at 24, 48, and 72 h for cytopathic effect (CPE). Negative samples were frozen and assayed again on a second passage in the same cells.
RESULTS
Replication of FMDV A 24 -B9 in different cell lines. Experimental serial infection of cattle in Colombia with an A 24 Cru FMDV prototype strain, using tongue inoculations, resulted in a virus isolated from the ninth serial passage (A 24 -B9) which was characterized by poor growth on BHK-21 cells. In contrast, a vaccine seed-derived virus, generated by seven passages of the A 24 -B9 virus on BHK-21 cells (A 24 -B9R7), had titers 100 to 500 times higher than A 24 -B9 and grew well on these cells. Bovines, immunized in Colombia, with vaccines derived from the A 24 -B9 virus, cultured in BHK-21 cells, had reduced efficiency in vaccine tests when the animals were challenged with the parental A 24 -B9 virus (G. Restrepo, Vecol, Colombia, per-sonal communication). Sequence data collected in our laboratory from PCR amplicons encoding the virus P1 (capsid) regions revealed the presence of only one amino acid difference between these two viruses (Fig. 1a) . An Arg at position 144 (R 144 ) in the VP1 R 144 GD motif was found in the cell-adapted A 24 -B9R7 virus, while an S 144 at that position, which changed the receptor-binding motif to an S 144 GD, characterized the parental A 24 -B9 virus. Examination of A 24 -B9 on BHK-21 cells revealed turbid plaque morphology (Fig. 1b) , low plaquing efficiency, and poor ability to cause CPE. A second passage of the SGD virus in these cells resulted in the rapid development of CPE and the concomitant enrichment of a virus subpopulation exhibiting a clear plaque phenotype and a mix of S and R at position 144 of VP1 (data not shown). Consistently, the RGD-containing A 24 -B9R7 virus caused CPE within 24 h postinfection, generated high titers, and formed clear plaques on BHK-21 cultures.
Initial experiments were designed to evaluate the susceptibility of secondary FBK, BHK-21, and BHK3-␣ V ␤ 6 cells to infection by the bovine A 24 -B9 virus isolate. Each of these cell lines was infected and subjected to consecutive passages with the resulting virus progeny. As shown in Table 1 , the plaque phenotype, titers, and capsid-coding sequences of viruses derived from passages on FBK and BHK3-␣ V ␤ 6 cells were similar to the corresponding properties of the parental A 24 -B9 used to initiate the infections. One to two passages of the SGD virus on BHK-21 cells, however, selected a virus that shared the RGD genotype and tissue culture phenotype of A 24 -B9R7 virus, suggesting the existence of a competitive advantage of the RGD over the SGD genotype during propagation in these cells. Mutations correlating with adaptation in different cell lines all mapped to the G-H loop of VP1 at positions S 144 3R, and E 148 3K and following 10 passages on BHK cells a V 155 3A accompanied the acquisition of the S 144 3R change. However, this A by itself did not appear to be the main determinant for virus growth in cells. To produce virus stocks and to determine virus titers of SGD-containing viruses, we utilized BHK3-␣ V ␤ 6 cells, since they were equally sensitive in determining PFU/ml values (by showing defined plaque morphologies in these cells) as using immunohistochemical staining assays in BHK-21 cells (data not shown).
Construction and in vitro characterization of wild-type and G-H loop mutants of A 24 Cru FMDVs. To examine the abilities of RGD-and SGD-containing viruses to infect cells and cause disease in susceptible animals, we produced full-length cDNA molecules by substitution of the RRGDMGS G-H loop sequence of an infectious A 24 Cru cDNA clone (pA 24 Cru [see Materials and Methods]) by an RSGDMES sequence found in the corresponding region of the A 24 -B9 virus. Two mutants were designed to contain either a single AGA3AGU codon change at position 144 of VP1 (A 24 -B9-like, designated pA 24 RSGD) or an AGA3UCA double mutation (designated pA 24 R*SGD) that imposes a restriction for reversion to the RGD sequence found in the parental virus. We were also interested to determine if the conserved R 143 residue at the Ϫ1 SGD position found in the two type A "SGD" variants described so far (Fig. 1, A 10 61 virus, and A 24 -B9 in the text) influenced cell receptor recognition. Accordingly, we constructed two additional mutant cDNAs (Table 2) to either preserve the basic nature of the residue at position 143 (AGA AGA3AAA UCA, designated pK*SGDMES) or to change it to an acidic residue (AGA AGA3GAA UCA, designated p*E*SGDMES). Transcript RNAs derived from the plasmids listed in Table 2 were checked for their ability to cause CPE and produce plaques following transfection into BHK-21 and BHK3-␣ V ␤ 6 cells in two independent experiments. Data in Table 2 show that A 24 -RRGD RNA produced CPE on both transfected cell types, and their progeny viruses formed clear plaques with a similar efficiency on monolayers of either cell type. Large clear plaques were noted on BHK-21 cells transfected with RSGDMES RNA, and after two passages the SGD appeared to be completely replaced by virus encoding the RGD motif and expressing a clear plaque phenotype. Thus, the SGD3RGD reversion allowed for improvement in cell culture growth. When the same genomic RNA was transfected and subsequently passed on BHK3-␣ V ␤ 6 cells, the turbid plaque phenotype and G-H loop sequence were preserved (Table 2) . Significant low affinity for BHK-21 cells and a turbid plaque phenotype clearly distinguished the R*SGDMES, K*SGDMES, and *E*SGDMES double mutants following passages on BHK3-␣ V ␤ 6 and BHK-21 cells (Table 2) ; however, the acquisition of a change at position 147 (E3A) was observed following passages in BHK-21 cells. Virus derived from *E*SGDMES RNA acquired additional changes in BHK3-␣ V ␤ 6 cells but only in one out of two experiments performed, including VP3 (E 196 3V) and VP4 (N 41 3K). Similarly, in one experiment an additional change in VP2 (D 85 3H) was incorporated in the K*SGDMES virus during propagation in BHK-21 cells.
Receptor specificity of RGD and SGD A 24 Cru viruses. The in vitro characteristics for the A 24 B9 virus described above appear to be related to alterations on the virion's surface within the cell receptor-binding site. In order to determine preferences for integrin recognition by SGD and RGD A 24 viruses, infection/labeling assays in COS-1 cells, previously 
a The A 24 -B9 virus amino acid residues 143 to 156 in VP1, with the SGD triplet in boldface letters, is displayed. The dashes represent conserved residues, and the emergent mutations from the original virus are indicated.
transfected with specific bovine integrins (see Materials and Methods) were performed. The results of these experiments are shown in Fig. 2 . Under these conditions, A 24 -RGD viruses replicated in cells expressing the ␣ V ␤ 1 , ␣ V ␤ 3 , and ␣ V ␤ 6 bovine integrins (Fig. 2a) , a result consistent with previous studies on A 24 Cru (17). Interestingly, a different pattern emerged from the SGD viruses (Fig. 2b) , including the original A 24 -B9 virus and R*SGDMES, K*SGDMES, *E*SGDMES, and E*SGDMAS mutant viruses derived from full-length clones. All of these SGD viruses only utilized the bovine ␣ V ␤ 6 integrin receptor, and this effect was independent of mutations at the Ϫ1 and ϩ2 positions relative to the SGD motif. The specificity for the ␣ V ␤ 6 bovine integrins by the A 24 RGD or SGD viruses has been also demonstrated by blocking the entry of these viruses in transfected COS-1 cells in the presence of soluble ␣ V ␤ 6 bovine integrins or by using a receptor-specific antibody (results not shown). Taken together these results indicate that acquisition of RGD during tissue culture adaptation increased the efficiency of the type A 24 Cru virus for integrins carrying ␤ 1 and ␤ 3 integrin subunits.
Pathogenicity of RGD and SGD A 24 Cru viruses in cattle.
To examine the influence of the receptor specificity on pathogenicity and the ability to transmit disease in cattle, we performed direct inoculation of recombinant RGD and SGD A 24 Cru viruses in bovines, followed by contact exposure of naïve steers to determine disease transmission. After inoculation, a number of disease parameters were analyzed, including fever, clinical score, viremia, and neutralizing antibodies. Samples of nasal swabs were also collected daily until 7 days postcontact in cohoused animals to measure viral excretion. Plasmid pA 24 RSGDMES was used to produce transcript RNAs in vitro and then introduced into either BHK-21 or BHK3-␣ V ␤ 6 cells, and viruses (designated A 24 -RGD and A 24 -SGD) were recovered and amplified in the same cell type (Table 2) . Virus stocks were prepared following amplification in these cells (passage 3), and the sequences of their P1 regions were compared to the original cDNA. As shown in Table 2 . By 24 h, this animal showed fever and extensive tissue damage at the inoculation sites. By day 2 the animal developed a measurable viremia, and lesions had formed on all four feet and beyond the sites of inoculation in the mouth, giving the maximal score achievable (Fig. 3a) and establishing a PFU/BID 50 ratio of 3.5 (see Materials and Methods). Vesicular fluid was collected from foot lesions on the second and third days postinoculation, and each sample was separately processed for RT-PCR and sequencing (Table 3) . These fluids contained virus that produced turbid plaques on BHK-21 cells and were indistinguishable from the inoculated virus in their capsid sequences, further indicating that the SGD virus had not changed during bovine growth. A contact bovine (number 15) housed together with bovine 22 on day 2 postinoculation developed lesions characteristic of FMD in three feet on day 7 and all four feet by day 8 postcontact which correlated with a high level of viremia (Fig. 3c) , but no fever was detected in this animal during the length of the experiment. Virus recovered from blood and vesicular lesions from bovine 15 showed the same SGD virus genotype as the inoculated animal (bovine 22) with no other changes in the capsid region and a turbid plaque phenotype (Table 3) . Virus A 24 -RGD was inoculated into bovine 21 with a total dose of 1.05 ϫ 10 5 PFU in a similar experimental design as described above. This animal developed clinical manifestations of FMD and viremia by day 2 and achieved the maximal score of lesions on day 3 (Fig. 3b) . The specific infectivity, determined as the PFU/BID 50 ratio, was 3.1, a result similar to that observed with the SGD virus. However, the virus with the RGD sequence transmitted the disease to the contact animal more rapidly, as judged by viremia and the appearance of vesicles in all feet by day 4 postexposure in bovine 18 (Fig. 3d) . This result might be attributed to a higher load of virus present in infected bovine 21 at the time when the 
a Transfections with transcript RNAs derived from the indicated sources were carried out as described in Materials and Methods. Transfections were repeated twice in each cell line. The * indicates that a double mutation was introduced in the coding sequence of the amino acid just downstream of the symbol relative to the sequence found in the wild-type (RGD) virus. wt, wild type.
b Sequence of amino acids 143 to 149 of VP1. c Growth properties of wild-type and mutant FMDVs. ϩϩϩ, wild-type growth; ϩϩ, slower than wild-type growth. Plaque phenotype on BHK-21 cell monolayers stained at 48 hours postinoculation was scored as turbid (T) or clear (C).
d Virus derived from two independent transfections in BHK-21 or BHK3␣ v ␤ 6 cells was passaged two additional times in the same cell line and the P1 sequences were determined. The wild-type A 24 Cruz virus 143-149 VP1 sequence encoding the RGD triplet (underlined) is displayed; the dashes represent conserved residues, and the emergent mutations from the original cDNA are indicated in boldface letters.
e The result of two transfection experiments is indicated.
contact animal was moved into the room (Fig. 3b, day 2 postinfection). Table 3 also shows that all of the samples collected from directly inoculated bovine 21 and contact bovine 18 contained an RGD motif, no changes in the capsid region from the inoculated virus (A 24 -RGD), and clear plaque phenotypes on BHK-21 cell monolayers. Figure 4 shows the results of virus neutralization assays performed with the SGD or RGD viruses using sera collected prior to inoculation and at days 7, 14, and 21 postinoculation from bovines 22 (Fig. 4a) and 21 (Fig. 4b) . The profile of neutralizing titers and determination of the bilateral relationship (see Materials and Methods), which was established as R ϭ 97%, further indicate that these viruses are very closely related.
DISCUSSION
FMDV, like other RNA viruses, has been shown to adapt to new environments through rapid selection of mutants from a quasispecies population (16) . The intrinsic genetic variability of FMDV, which has been manifested by changes in antigenicity in FMDV escape mutants (14, 35, 50, 51) , and diversity in cellular receptor usage (5, 8, 21, 24, 26, 31, 34, 40) pose concerns for control strategies based on vaccination. The fact that current FMDV vaccines are prepared from virus grown in large amounts in cell cultures generates potential problems in vaccine manufacturing, due to the occasional outgrowth and dominance of mutant viruses. As we, and others, have shown, adaptive changes during passages in cell culture result in animal-derived FMDVs either increasing the efficiency of integrin utilization in vitro or acquiring alternative pathways of entry into the cells (for reviews, see references 7 and 23), such as acquisition of attachment to heparan sulfate (22, 48) , or the possible usage of an alternative, as-yet-unidentified receptor in vitro (5, 31, 53) . The specific virus (A 24 -B9) used in the present study was derived from a Colombian A 24 Cruzeiro reference strain, following nine serial passages in naïve cattle using tongue inoculations. This virus exhibited low fitness to BHK-21 cells, exemplified by a turbid plaque phenotype and overall low virus yields. Upon passage in vitro, variants with apparent growth advantages in cell culture were selected which exhibited a clear plaque phenotype and yields about two orders of mag- Sequence analysis revealed the presence of only one amino acid change in the viral capsid region that distinguished the A 24 -B9 virus from its tissue culture derivative (A 24 -B9R7), mapping to the conserved RGD motif thought to be essential for integrin recognition. Remarkably, the A 24 -B9 virus carried an atypical SGD sequence in this position that was maintained during passages on secondary FBK cells or BHK3-␣ V ␤ 6 , a cell line engineered to express the bovine ␣ V ␤ 6 integrin (18). Although one additional mutation (E 148 3K) was selected on third passage on FBK cells and maintained throughout subsequent passages on BHK-21 cells, it did not covary with the S 144 3R alteration in the cell receptor-binding site, as judged by it absence on viruses recovered from six passages in either BHK3-␣ V ␤ 6 or BHK-21 cells (Table 1) . Additional amino acid substitutions relative to the sequence of the A 24 Cru infectious cDNA clone were observed in the Colombian A 24 -B9 virus at position 148 (G 148 3E) of VP1 and in 3C pro (not shown), although the latter appeared to be unlikely to influence adaptation to cell culture.
The mechanism by which cell culture-adapted variants are selected by BHK-21 cells is of interest, since it may mimic other adaptation processes leading to alteration in virulence. The evidence presented here strongly suggests a role for the early interaction between the virus and the cell surface as the major selective force in amplifying variant virus populations. (Table 2 ). In contrast, and in agreement with previous evidence for type A FMDVs (17), RGDMES and RGDMGS viruses replicated in COS-1 cells expressing bovine integrins ␣ V ␤ 1 , and ␣ V ␤ 3 and, to a lesser extent, on those cells expressing ␣ V ␤ 6 . Furthermore, the results also indicate that the residue immediately preceding the SGD motif (R 143 3K/E at the Ϫ1 SGD position) or the changes acquired at the ϩ2 position (G, A, or E) are not the main determinant of integrin binding specificity in vitro, but they could modulate the affinity to the specific cell receptor. Although our assay does not detect subtle differences in receptor binding affinity, it is possible to speculate that the adaptive mutations (residues 144, 148, and 155 in VP1, 85 in VP2, and 196 in VP3) ( Table 2 ) acquired during virus successive passages in FBK or BHK-21 cells (Tables 1 and 2) could account for affinity gain to the specific cell receptor. This is supported by early reports showing that, depending upon the serotype of the virus, amino acids surrounding the RGD motif or located in other regions of the viral capsid could also influence the virus-receptor interaction (14, 17, 31, 42) . To analyze the effect that a change in the viral receptorbinding site had on FMDV virulence and transmission in an animal naturally susceptible to the disease, we designed tongue inoculation and contact transmission experiments in cattle using the A 24 -SGD and A 24 -RGD viruses. Regardless of their differences in receptor utilization and ability to grow in BHK-21 cell monolayers, both SGD and RGD recombinant viruses were highly virulent to bovines (PFU/BID 50 ratios of 3.5 and 3.1, respectively), caused rapid onset of clinical disease upon exposure, and transmitted FMDV to cohoused animals. The A 24 -SGD virus produced more extensive tissue damage at the injected sites and induced fever and vesicles a day earlier than in the A 24 -RGD-inoculated animal, which indicate a different degree of disease severity. However, a larger number of test animals will be required to confirm this trend. The apparent high virulence of the SGD virus was also supported by the maintenance of an SGD sequence (only one nucleotide change is required to mutate to an RGD motif) in blood and vesicle samples obtained from infected and contact animals. This further suggests that viruses with sequences other than RGD, but closely related to it, can still infect via integrin receptors and induce and transmit the disease to susceptible animals. These observations are particularly interesting since the presence of an RGD motif is believed to be the main determinant to direct FMDV to integrin-containing target tissues during infection in the natural host (2, 6, 7) . While conservation of the RGD sequence in the protruding VP1 G-H loop in FMDV field isolates has been extensively reported (see introduction), a type C virus containing a mutated RGGD sequence has been isolated from bovine which was not protected from virus challenge following experimental immunization with a peptide vaccine (50, 51) . Moreover, a cell-adapted type C virus, engineered to contain an RGG sequence, was able to infect cells in both an integrin-and heparin-independent manner (4, 5) . Although these findings suggest the possibility of a nonintegrin receptor being involved in FMD, there has been no demonstration of the ability of these viruses to produce disease in susceptible animals.
It is not clear why amplification of type A 24 Cru in cattle selected an SGD variant (via a single point mutation) that utilizes only the ␣ V ␤ 6 integrin in vitro, while the original RGD virus utilizes multiple (␣ V ␤ 1 , ␣ V ␤ 3 , Ͼ␣ V ␤ 6 ) integrin receptors. It is possible that the route of inoculation and the availability of appropriate integrin receptor molecules on the cells at the portal of entry may be the determining factor. Specifically, Breuss and coworkers (10) have reported that ␣ V ␤ 6 is expressed exclusively in epithelial cells, the cell type preferentially infected by FMDV in the susceptible host (2, (11) (12) (13) , and ␣ V ␤ 6 appears to be the predominant integrin expressed in bovine tissues which also express viral antigen in infected animals (V. O'Donnell and B. Baxt, unpublished data). What is clear, however, is that once the SGD sequence has been established, there does not appear to be any selective pressure to change it to an RGD by infecting the animal either via IDL inoculation or direct contact. Given the evidence that the immune response to the SGD and RGD viruses, measured by levels of neutralizing antibodies, was very similar and crossneutralization assays suggested that these viruses are very closely related (R ϭ 97%), one could speculate that the SGD virus with enhanced utilization of ␣ V ␤ 6 integrin in bovine epithelium could induce an imbalance favoring virus replication over the host immune defense, other than neutralizing antibodies, which could explain the reduced efficiency of an A 24 -RGD vaccine in cattle when using A 24 -SGD challenge virus. . The antigenic bilateral relationship (R value) between these viruses was determined by a cross-neutralization assay using polyclonal antisera obtained at 21 dpi from bovines 21 and 22.
